Edwards Lifesciences Options Market Pricing in 5% Post-Earnings Move

The options market is pricing in a potential 5% move in either direction for Edwards Lifesciences Corp. (EW) shares following the company's upcoming earnings announcement, according to data compiled by Bloomberg. The medical device maker is scheduled to release its financial results after the market closes on July 23.

Historical Performance vs. Expectations

An analysis of the company's last eight earnings reports reveals a mixed record of actual stock performance compared to the movements implied by options prices. The stock's price change has exceeded the market's expectation in three of those eight instances.

In its most recent report on April 23, Edwards Lifesciences shares moved 7.6%, which was greater than the 6.7% swing traders had priced in. Conversely, the February 10 report saw the stock decline by 4%, a smaller move than the 5.7% implied volatility had suggested.

Notable Past Volatility

The historical data includes periods of significant deviation from market expectations, underscoring the potential for earnings surprises. Key past performance includes:

Ad

• Largest Discrepancy (July 24, 2024): The stock plunged 32%, a far more dramatic move than the modest 5.7% implied by options.
• Matched Expectation (Oct. 30, 2025): The actual price change of 7.3% exactly matched the options-implied movement.
• Significant Under-reaction (Oct. 24, 2024): Shares moved just 1.6% despite options traders anticipating a much larger 10.2% swing.

What This Means for Investors

The options-implied move is a key metric derived from trading activity in puts and calls, reflecting the market's consensus on potential post-earnings volatility. It is a measure of expected risk, not a price prediction.

For traders and investors, this data provides a baseline for how much volatility is anticipated around the earnings event. The historical performance of Edwards Lifesciences stock illustrates that while the options market provides a useful gauge, the actual reaction can be significantly more or less pronounced depending on the results and forward guidance provided by the company.